Video

Why future research must be conducted for prevention of LUTS and BPH

Author(s):

Urology Times staff

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Jordan J. Kramer, MD, discusses why the findings of the REDUCE trial warrant further research into the prevention of LUTS and BPH. Kramer is a PGY4 urology resident at Cedars Sinai Medical Center, Los Angeles, California.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
      Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Urologist finds Rezum AE rates in larger prostates “reassuring”
      Kevin T. McVary, MD, FACS, answers a question during a Zoom video interview
      Kevin T. McVary, MD, FACS, discusses the expanded label for Rezum in BPH
      Amy Krambeck, MD, on considerations for building clinical programs in endourology
      Amy Krambeck, MD, on considerations for building clinical programs in endourology
      Connor Forbes, MD, on trends in surgical procedures for BPH
      Connor Forbes, MD, on trends in surgical procedures for BPH
      Dean Elterman, MD, on the shift toward personalized care in BPH
      Dean Elterman, MD, on the shift toward personalized care in BPH
      Dean Elterman, MD, shares 3-year data on Zenflow Spring System for BPH
      Dean Elterman, MD, shares 3-year data on Zenflow Spring System for BPH
      1 expert in this video
      Adoption of New Treatment Modalities to Treat BPH
      1 expert in this video
      BPH: Strategies for Guiding Patients From Medication to Intervention
      1 expert in this video
      Impact of Robotic Procedures and Apps on Clinic Efficiency
      Related Content
      FDA logo
      July 3rd 2025

      FDA news recap in urology for Q2 2025

      Hannah Clarke Benjamin P. Saylor Jason M. Broderick
      Here’s a look back at notable news between April and June 2025.
      male patient sitting in clinic room while doctor talks with him
      May 23rd 2023

      Dr. Gange discusses data on the UroLift System for BPH

      Urology Times staff
      The data were presented at the recent American Urological Association Annual Meeting.
      FDA approves label expansion for Rezūm Water Vapor Therapy for BPH
      June 20th 2025

      FDA approves label expansion for Rezūm Water Vapor Therapy for BPH

      Hannah Clarke
      The approval is supported by several studies highlighting the efficacy of Rezūm Water Vapor Therapy in patients with larger prostates.
      Destigmatizing Urology: Dr. McVary discusses enlarged prostates
      February 8th 2022

      Destigmatizing Urology: Dr. McVary discusses enlarged prostates

      Urology Times staff
      “Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.
      Expert discusses the promise of emerging MISTs for BPH
      May 23rd 2025

      Expert discusses the promise of emerging MISTs for BPH

      James C. Ulchaker, MD Hannah Clarke
      James C. Ulchaker, MD, shares his insights on the current range of BPH therapies.
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      May 11th 2025

      We got a little MIST-y at this year’s AUA Annual Meeting

      Garrett D. Pohlman, MD
      Urologist Garrett D. Pohlman, MD, reflects on the benign prostatic hyperplasia offerings from the 2025 American Urological Association Annual Meeting.
      © 2025 MJH Life Sciences

      All rights reserved.